P-59 Association of B cell subsets and aquaporin-4 antibody titers with disease activity in participants in the N-MOmentum trial receiving inebilizumab treatment. (April 2023) - Paul, F.; Pittock, S.; Kim, H.J.; Smith, M.; Rees, W.; Patterson, K.; Cree, B.; Bennett, J.